Background: The most important prognostic determinant in cancer is the iden
tification of disseminated tumour burden (metastases). Micrometastases are
microscopic (smaller than 2 mm) deposits of malignant cells that are segreg
ated spatially from the primary tumour and depend on neovascular formation
(angiogenesis) to propagate.
Methods: The electronic literature (1966 to present) on micrometastases and
their implications in malignant melanoma and epithelial cancers was review
ed.
Results: Immunohistochemical techniques combined with serial sectioning off
er the best accuracy for detection of nodal micrometastases. Molecular tech
niques should be reserved for blood samples or bone marrow aspirates. Detec
tion of micrometastases in regional lymph nodes and/or bone marrow confers
a poor prognosis in epithelial cancers. The concept of sentinel node biopsy
combined with serial sectioning and dedicated screening for micrometastase
s may improve staging procedures. Strategies against angiogenesis may provi
de novel therapies to induce and maintain micrometastatic dormancy.
Conclusion: The concept of micrometastases has resulted in a paradigm shift
in the staging of epithelial tumours and our overall understanding of mali
gnant processes.